Inovio Pharmaceuticals, Inc. (INO) Financial Statements (2024 and earlier)
Company Profile
Business Address |
6769 MESA RIDGE RD. SAN DIEGO, CA 92121 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments, including: | 253,000 | 401,300 | 411,600 | 89,500 | 81,200 | 127,425 | |||
Cash and cash equivalents | 46,329 | 71,144 | 250,728 | 22,196 | 23,694 | 23,787 | |||
Short-term investments | 206,669 | 330,171 | 160,915 | 67,338 | 57,539 | 103,639 | |||
Other undisclosed cash, cash equivalents, and short-term investments | 1 | (15) | (43) | (34) | (32) | ||||
Receivables | 11,738 | 8,032 | 19,064 | 2,032 | 4,055 | 6,490 | |||
Prepaid expense | 18,729 | 11,363 | 4,696 | ||||||
Other undisclosed current assets | 31,775 | 27,750 | 35,811 | 2,669 | 2,560 | 4,447 | |||
Total current assets: | 315,243 | 448,445 | 471,171 | 94,201 | 87,815 | 138,362 | |||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 10,228 | 11,571 | 12,741 | 13,783 | ✕ | ✕ | |||
Property, plant and equipment | 7,728 | 17,453 | 11,348 | 12,773 | 15,949 | 18,320 | |||
Long-term investments and receivables | 434 | 9,400 | 9,069 | ||||||
Long-term investments | 434 | 9,400 | 9,069 | ||||||
Intangible assets, net (including goodwill) | 12,643 | 13,140 | 13,660 | 14,207 | 15,274 | 16,523 | |||
Goodwill | 10,513 | 10,513 | 10,513 | 10,513 | 10,513 | 10,513 | |||
Intangible assets, net (excluding goodwill) | 2,130 | 2,626 | 3,147 | 3,694 | 4,760 | 6,010 | |||
Other noncurrent assets | 684 | 1,426 | 25,957 | 2,672 | 2,670 | 2,639 | |||
Other undisclosed noncurrent assets | 2,007 | 3,907 | 4,460 | 6,315 | 6 | 2,325 | |||
Total noncurrent assets: | 33,291 | 47,497 | 68,602 | 49,751 | 43,298 | 48,877 | |||
TOTAL ASSETS: | 348,533 | 495,941 | 539,772 | 143,952 | 131,113 | 187,239 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 79,687 | 47,645 | 21,204 | 18,237 | 23,135 | 23,279 | |||
Employee-related liabilities | ✕ | ✕ | 16,113 | 13,127 | 8,968 | 9,467 | 7,997 | ||
Accrued liabilities | 12,575 | 5,672 | 8,612 | ||||||
Other undisclosed accounts payable and accrued liabilities | 67,112 | 31,532 | 8,077 | 9,269 | 7,996 | 6,670 | |||
Deferred revenue | 22 | 47 | 92 | ✕ | ✕ | ||||
Debt | 2,075 | ||||||||
Deferred rent credit | 1,065 | ✕ | |||||||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 2,053 | ||
Due to related parties | ✕ | 1,220 | 548 | 643 | 730 | 978 | 927 | ||
Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 224 | ✕ | ||
Other undisclosed current liabilities | 15,961 | 17,527 | 19,813 | 10,855 | 9,898 | 9,147 | |||
Total current liabilities: | 96,868 | 65,742 | 41,706 | 31,989 | 35,300 | 35,405 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation: | 15,460 | 18,064 | 20,410 | ||||||
Liabilities, other than long-term debt | 12,688 | 111 | 169 | 8,990 | 8,756 | 9,320 | |||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 9,320 | ||
Deferred revenue | 64 | 79 | 102 | ✕ | ✕ | ||||
Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | ✕ | 151 | ✕ | ||
Deferred rent credit | 8,518 | ✕ | |||||||
Deferred income tax liabilities | 32 | 32 | 32 | 32 | ✕ | ✕ | |||
Other liabilities | 15 | 58 | 37 | 87 | |||||
Operating lease, liability | 12,656 | 15,460 | 18,064 | 20,410 | ✕ | ✕ | |||
Derivative instruments and hedges, liabilities | 8,819 | ||||||||
Other undisclosed noncurrent liabilities | 16,615 | 14,960 | 18,693 | 77,158 | 25 | 25 | |||
Total noncurrent liabilities: | 29,302 | 30,530 | 36,926 | 106,557 | 8,781 | 9,345 | |||
Total liabilities: | 126,171 | 96,272 | 78,632 | 138,547 | 44,081 | 44,750 | |||
Equity | |||||||||
Equity, attributable to parent | 222,363 | 399,669 | 461,141 | 3,435 | 86,936 | 142,393 | |||
Common stock | 253 | 217 | 187 | 101 | 97 | 90 | |||
Additional paid in capital | 1,710,656 | 1,609,590 | 1,367,407 | 742,647 | 707,794 | 665,776 | |||
Accumulated other comprehensive income (loss) | (699) | (282) | (256) | 473 | (529) | (117) | |||
Accumulated deficit | (1,487,848) | (1,209,856) | (906,197) | (739,786) | (620,426) | (523,356) | |||
Equity, attributable to noncontrolling interest | 1,970 | 96 | 96 | ||||||
Total equity: | 222,363 | 399,669 | 461,141 | 5,405 | 87,032 | 142,489 | |||
TOTAL LIABILITIES AND EQUITY: | 348,533 | 495,941 | 539,772 | 143,952 | 131,113 | 187,239 |
Income Statement (P&L) ($ in thousands)
9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 10,262 | 3,363 | 7,411 | 4,112 | 30,482 | 42,220 | ||
Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 42,220 | |
Net investment income | 4,782 | 3,363 | 3,312 | 2,606 | ||||
Gross profit: | 10,262 | 3,363 | 7,411 | 4,112 | 30,482 | 42,220 | ||
Operating expenses | (277,836) | (302,993) | (131,493) | (115,220) | (124,573) | (125,863) | ||
Other undisclosed operating loss | (1,588) | |||||||
Operating loss: | (267,574) | (301,218) | (124,082) | (111,109) | (94,091) | (83,643) | ||
Nonoperating income (expense) | (3,862) | 343 | 3,416 | 496 | ||||
Investment income, nonoperating | 4,121 | |||||||
Other nonoperating income (expense) | (3,862) | 343 | (705) | 496 | ||||
Interest and debt expense | (1,254) | (1,936) | (8,702) | (7,949) | ||||
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes | (4,964) | |||||||
Loss from continuing operations before equity method investments, income taxes: | (277,653) | (302,811) | (129,368) | (118,561) | (94,091) | (83,643) | ||
Loss from equity method investments | (2,165) | |||||||
Other undisclosed income (loss) from continuing operations before income taxes | 2,166 | (413) | (33,522) | (2,248) | (707) | (4,563) | ||
Loss from continuing operations before income taxes: | (277,652) | (303,224) | (162,890) | (120,809) | (94,798) | (88,206) | ||
Income tax expense (benefit) | 257 | (2,170) | ||||||
Loss from continuing operations: | (277,652) | (303,224) | (162,890) | (120,552) | (96,968) | (88,206) | ||
Loss before gain (loss) on sale of properties: | ✕ | ✕ | (303,224) | (162,890) | (120,552) | (96,968) | (88,206) | |
Other undisclosed net loss | (2,166) | (434) | (4,585) | |||||
Net loss: | (279,818) | (303,659) | (167,475) | (120,552) | (96,968) | (88,206) | ||
Net income attributable to noncontrolling interest | 1,064 | 1,193 | ||||||
Net loss attributable to parent: | (279,818) | (303,659) | (166,411) | (119,359) | (96,968) | (88,206) | ||
Other undisclosed net loss available to common stockholders, basic | (807) | |||||||
Net loss available to common stockholders, diluted: | (279,818) | (303,659) | (166,411) | (119,359) | (96,968) | (89,013) |
Comprehensive Income ($ in thousands)
9/30/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (279,818) | (303,659) | (167,475) | (120,552) | (96,968) | (88,206) | ||
Other comprehensive income | 266 | |||||||
Other undisclosed comprehensive income (loss) | (417) | (26) | (729) | 735 | (180) | (1,445) | ||
Comprehensive loss: | (280,235) | (303,685) | (168,204) | (119,550) | (97,148) | (89,651) | ||
Comprehensive income, net of tax, attributable to noncontrolling interest | 1,064 | 1,193 | ||||||
Comprehensive loss, net of tax, attributable to parent: | (280,235) | (303,685) | (167,140) | (118,358) | (97,148) | (89,651) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.